Systematic Reviews of Treatments for Cirrhosis of the Liver

Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for cirrhosis of the liver.

Created January 2008

Printer friendly page

13 Resources Found
Results 1 to 13 displayed.
Title:   Methotrexate for primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Methotrexate tended to increase mortality or liver transplantation in patients with primary biliary cirrhosis. Primary biliary cirrhosis is an uncommon chronic liver disease of unknown etiology. Methotrexate, a folic acid antagonist with immunosuppressive...
Date:   Mar 2005
Title:   Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Evidence supporting colchicine for alcoholic, viral, and cryptogenic liver fibrosis/cirrhosis is still lacking ...
Date:   Feb 2005
Title:   Colchicine for primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   No convincing evidence either to support or refute the use of colchicine for patients with primary biliary cirrhosis ...
Date:   Feb 2004
Title:   Ursodeoxycholic acid for primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Primary biliary cirrhosis is an uncommon and slowly progressive autoimmune disease of the liver that primarily attacks middle-aged women. The cause of the disease is unknown. Over the last 30 years, substantial increases in the prevalence of primary bil...
Date:   Jan 2008
Title:   Glucocorticosteroids for primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   No evidence to support or refute glucocorticosteroids for patients with primary biliary cirrhosis. Primary biliary cirrhosis is a chronic progressive cholestatic liver disease of presumed autoimmune aetiology. The clinical course might be improved by gluc...
Date:   Feb 2005
Title:   Cyclosporin A for primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cyclosporin A was without significant effects on mortality, liver transplantation, or progression of primary biliary cirrhosis, and patients given cyclosporin A experienced more adverse eventsPrimary biliary cirrhosis (PBC) is a chronic disease of the l...
Date:   May 2007
Title:   Azathioprine for primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   There is no evidence to support azathioprine for patients with primary biliary cirrhosisPrimary biliary cirrhosis (PBC) is a chronic disease of the liver that is characterised by destruction of bile ducts. Estimates of annual incidence range from 2 to 2...
Date:   May 2007
Title:   Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Portosystemic shunts compared with sclerotherapy/banding lowers variceal rebleeding, but increases hepatic encephalopathyA third of deaths from cirrhosis are due to variceal bleeding. Randomised clinical trials have compared three types of portosystemic...
Date:   Aug 2006
Title:   Terlipressin for acute esophageal variceal hemorrhage
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Esophageal varices are abnormal dilatations of veins in the lower part of the swallowing tube (esophagus) that may develop in patients with chronic liver damage (cirrhosis). Bleeding from these varices is a life threatening complication with mortality b...
Date:   Oct 2002
Title:   Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients with liver cirrhosis can bleed from the gastrointestinal system. When these patients are hospitalised, they are prone to bacterial infections. Because bacterial infections increase the risk of death among these patients, antibiotic prophylaxis ...
Date:   Jan 2002
Title:   Emergency sclerotherapy versus medical interventions for bleeding oesophageal varices in cirrhotic patients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Variceal bleeding in cirrhosis is associated with a high risk of death. Emergency sclerotherapy and vasoactive drugs stop bleeding in most patients, but emergency sclerotherapy may carry risks to the patient and is more demanding on the health-care syst...
Date:   Nov 2001
Title:   Antacids for preventing oesophagogastric variceal bleeding and rebleeding in cirrhotic patients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Randomised trials with antacids for preventing oesophagogastric variceal bleeding and bleeding in cirrhotic patients could not be found. Valid evidence for or against the use of antacids for preventing oesophagogastric variceal bleeding and bleeding in ...
Date:   Feb 2008
Title:   TIPS versus paracentesis for cirrhotic patients with refractory ascites
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients with refractory ascites may temporarily benefit from transjugular intrahepatic portosystemic stent-shunts ...
Date:   Aug 2006
Results 1 to 13 displayed.